TRUADVICE’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
TRUADVICE's AMGN Position: Q3 2023 in Review
TRUADVICE increased its Amgen (AMGN) stake by 20% in Q3 2023, buying an estimated $39.4K and bringing the position to 959 shares worth $256K. The position accounts for 0.1% of the portfolio, ranked #192.
TRUADVICE first reported a position in AMGN in Q3 2020 and has held it in 6 quarters since. The position peaked at $905K in Q4 2020. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- TRUADVICE held 959 shares of Amgen worth $256K as of Q3 2023.
- TRUADVICE bought 158 Amgen shares in Q3 2023, an estimated $39.4K.
- Amgen made up 0.1% of TRUADVICE's portfolio in Q3 2023, its #192 holding.
- TRUADVICE first reported a position in Amgen in Q3 2020 and has held it in 6 quarters since.
- TRUADVICE's Amgen position peaked at $905K in Q4 2020.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.